#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Rectal cancer Selective polysaccharide antibody deficiency Angiosarcoma recurrent Pleomorphic liposarcoma Immune-mediated myositis Hypomagnesaemia Brain abscess Bronchiolitis Biliary cancer metastatic Postprandial hypoglycaemia Staphylococcal infection Proteus syndrome Antithrombin III deficiency Atypical haemolytic uraemic syndrome Hereditary angioedema with C1 esterase inhibitor deficiency More trials…

Learn about Rare Diseases

Mantle cell lymphoma refractory – Treatment Hereditary hypophosphataemic rickets – Basic Information Idiopathic pulmonary fibrosis CADASIL – Trials in Disease Behcet’s syndrome – Trials in Disease Familial amyotrophic lateral sclerosis Netherton’s syndrome – Life with Disease Hereditary angioedema – Basic Information Glycogen storage disease type V – Life with Disease Hereditary ataxia More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Relebactam Bms-986449-03 Tinengotinib Amantadine Hydrochloride Rapcabtagene Autoleucel Levosimendan Tenecteplase Omx-0407 Timolol Regn7075 Opevesostat Tosilate Nystatin Brepocitinib Tosilate Specific Nucleic Acid Sna-Her2 YOHIMBINE HYDROCHLORIDE Maraviroc Tyrosine Sodium Iodide Sunvozertinib Rilzabrutinib More therapies…

Learn about Your Condition

Craniopharyngioma Stomatitis Hepatic adenoma Primary hyperoxaluria Papillary thyroid cancer Labour pain Medulloblastoma recurrent Blood iron increased Oedema Sexual dysfunction Breast cancer male Deep vein thrombosis Anxiety Breast cancer stage I Neurodegenerative disorder More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Thalassaemia

Study on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia

Not recruiting

3 1
Investigated Diseases:
- Thalassaemia
Investigated Drugs:
- Mitapivat
+1
Study on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Not recruiting

3 1
Investigated Diseases:
- Thalassaemia
Investigated Drugs:
- Mitapivat
+2
Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:

1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Thalassaemia

Study on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia

Study on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies